Eveliqure

• Austria
• European Union
• France
• Germany
• Healthcare
• Hungary
• News
• Pharma & Biotech
• Science
• United Kingdom

Eveliqure announces the initiation of a Phase 1 clinical study of its combined Shigella and ETEC vaccine candidate

(PRESS RELEASE) VIENNA, 24-Sep-2020 — /EuropaWire/ — Eveliqure Biotechnologies GmbH, an Austrian biotechnology company, today announces the initiation of clinical…